Boothbay Fund Management’s GSK GSK Stock Holding History

Boothbay Fund Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.2M	Buy	+156,400	New	+$8.27M	0.11%	204
2025 Q3	–	Sell	-20,000	Closed	-$768K	–	1980
2025 Q2	$768K	Buy	+20,000	New	+$764K	0.01%	771
2024 Q4	–	Sell	-11,567	Closed	-$473K	–	1666
2024 Q3	$473K	Buy	+11,567	New	+$473K	0.01%	1007
2024 Q2	–	Sell	-238,676	Closed	-$10.2M	–	1665
2024 Q1	$10.2M	Buy	238,676 +25,026	+12%	+$1.03M	0.2%	75
2023 Q4	$7.92M	Sell	213,650 -490,672	-70%	-$17.6M	0.2%	95
2023 Q3	$25.5M	Sell	704,322 -128,186	-15%	-$4.55M	0.61%	14
2023 Q2	$29.7M	Buy	832,508 +23,736	+3%	+$851K	0.65%	11
2023 Q1	$28.8M	Buy	808,772 +368,413	+84%	+$12.9M	0.59%	9
2022 Q4	$15.5M	Buy	440,359 +221,930	+102%	+$7.39M	0.36%	26
2022 Q3	$6.43M	Buy	+218,429	New	+$8.28M	0.16%	116
2022 Q2	–	Sell	-94,850	Closed	-$5.17M	–	2418
2022 Q1	$5.17M	Buy	+94,850	New	+$5.15M	0.12%	203
2021 Q4	–	Sell	-10,198	Closed	-$487K	–	1996
2021 Q3	$487K	Buy	+10,198	New	+$512K	0.01%	1100

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Boothbay Fund Management's GSK Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in GSK (GSK) in Q2 2026: 156,400 shares worth $8.2M. The stake represents 0.11% of the portfolio and ranks #204 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in GSK as recently as Q2 2025.

Boothbay Fund Management first reported a position in GSK in Q3 2021 and has held it in 12 quarters since. The position peaked at $29.7M in Q2 2023. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Boothbay Fund Management held 156,400 shares of GSK worth $8.2M as of Q2 2026.
GSK was a new Boothbay Fund Management position in Q2 2026.
GSK made up 0.11% of Boothbay Fund Management's portfolio in Q2 2026, its #204 holding.
Boothbay Fund Management first reported a position in GSK in Q3 2021 and has held it in 12 quarters since.
Boothbay Fund Management's GSK position peaked at $29.7M in Q2 2023.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.